- Home
- PCRX vs GNK Comparison
PCRX vs GNK Comparison
Compare PCRX & GNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- GNK
- Stock Information
- Founded
- PCRX 2006
- GNK 2004
- Country
- PCRX United States
- GNK United States
- Employees
- PCRX N/A
- GNK N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- GNK Marine Transportation
- Sector
- PCRX Health Care
- GNK Consumer Discretionary
- Exchange
- PCRX Nasdaq
- GNK Nasdaq
- Market Cap
- PCRX 1.2B
- GNK 551.2M
- IPO Year
- PCRX 2011
- GNK 2005
- Fundamental
- Price
- PCRX $23.22
- GNK $13.95
- Analyst Decision
- PCRX Buy
- GNK Strong Buy
- Analyst Count
- PCRX 9
- GNK 4
- Target Price
- PCRX $29.89
- GNK $20.75
- AVG Volume (30 Days)
- PCRX 560.0K
- GNK 715.7K
- Earning Date
- PCRX 07-29-2025
- GNK 08-06-2025
- Dividend Yield
- PCRX N/A
- GNK 10.47%
- EPS Growth
- PCRX N/A
- GNK 1259.97
- EPS
- PCRX N/A
- GNK 1.05
- Revenue
- PCRX $702,772,000.00
- GNK $376,850,000.00
- Revenue This Year
- PCRX $7.54
- GNK N/A
- Revenue Next Year
- PCRX $10.78
- GNK $2.54
- P/E Ratio
- PCRX N/A
- GNK $13.34
- Revenue Growth
- PCRX 3.08
- GNK N/A
- 52 Week Low
- PCRX $11.16
- GNK $11.20
- 52 Week High
- PCRX $27.64
- GNK $22.18
- Technical
- Relative Strength Index (RSI)
- PCRX 34.52
- GNK 55.29
- Support Level
- PCRX $22.82
- GNK $12.92
- Resistance Level
- PCRX $24.36
- GNK $13.66
- Average True Range (ATR)
- PCRX 0.69
- GNK 0.39
- MACD
- PCRX -0.12
- GNK 0.02
- Stochastic Oscillator
- PCRX 12.39
- GNK 65.80
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.